What does the PIPE-307 MOONLIGHT-1 miss mean for Contineum Therapeutics stock?
Contineum shares face pressure after Johnson & Johnson’s PIPE-307 misses its Phase 2 depression endpoint, shifting attention to PIPE-791.
Pharma & Biotech